| European Federation of Internal Medicine

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 30 October 2025 - 8:49

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 8, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 8, Status: Authorised

Clinical Trials Information System

Submitted by Anonymous (not verified) on 29 October 2025 - 15:59

Clinical Trials Information System

Read more about Clinical Trials Information System

Human medicines European public assessment report (EPAR): Lytgobi, futibatinib, Date of authorisation: 04/07/2023, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 29 October 2025 - 15:25

Human medicines European public assessment report (EPAR): Lytgobi, futibatinib, Date of authorisation: 04/07/2023, Revision: 3, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Lytgobi, futibatinib, Date of authorisation: 04/07/2023, Revision: 3, Status: Authorised

Unlocking PMS API potential: Edit functionality training for MAHs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2025, 10:00 (CEST) to 16 October 2025, 11:30 (CEST)

Submitted by Anonymous (not verified) on 29 October 2025 - 14:43

Unlocking PMS API potential: Edit functionality training for MAHs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2025, 10:00 (CEST) to 16 October 2025, 11:30 (CEST)